Table 1

WHO trial registration data set

Data categoryInformation
Primary registry and trial identifying numberclinicaltrials.gov NCT02608333
Date of registration in primary registry11 May 2015
Secondary identifying numbersFrench institutional review board (2015–013B)
sponsor (69HCL15_0278)
Source of monetary or material supportFrench Ministry of Health (Programme de Recherche sur la Performance du Système de soins)
Fondation de France (member of the Network of European Foundations for Innovative Cooperation)
Primary sponsorCentre Hospitalier Le Vinatier, Bron, France
Secondary sponsorNot applicable
Contact for public queriesMarie-Maude Geoffray (PI), email: marie-maude.geoffray @ch-le-vinatier.fr
Sandrine Touzet, email: sandrine.touzet@chu-lyon.fr
Amelie Zelmar, email: amelie.zelmar@chu-lyon.fr
Contact for scientific queriesMarie-Maude Geoffray (PI), email: marie-maude.geoffray @ch-le-vinatier.fr
Sandrine Touzet (scientific contact), email: sandrine.touzet@chu-lyon.fr
Public titleImpact of the Early Start Denver Model (ESDM) on the cognitive level of children with autism spectrum disorder.
Scientific titleImpact of the ESDM on the cognitive level of children with autism spectrum disorder: study protocol for a randomised controlled trial using a two-stage Zelen design. IDEA study.
Countries of recruitmentFrance and Belgium
Health condition or problem studiedAutism spectrum disorder (ASD)
InterventionsIntervention: ESDM for toddlers and young children with ASD
Description: ESDM delivered by trained therapists 10 hours per week at the intervention unit and 2 hours per week in the toddlers' natural environment (home, nursery, preschool).
Control: care available in the community, i. e. consultations with a psychologist or child and adolescent psychiatrist, speech and language therapy, occupational therapy, individual or group psychotherapy.
Key inclusion and exclusion criteriaAge: between 15 and 36 months
Sex: male or female
Inclusion criteria: diagnosis of ASD (Diagnosis and Statistical Manual of Mental Disorders, Fifth Edition, and Autism Diagnosis Observation Schedule), DQ of 30 or above at the MSEL, family living within 40 min of an ESDM unit. Exclusion criteria: serious neurological or physical condition, diagnosis of Rett syndrome, family unavailable for a regular follow-up and intervention.
Study typeInterventional
Allocation: randomised 1:2; parallel assignment; blinding: assessor blind; two-stage modified Zelen design
Date of first enrolmentNA
Target sample size180
Recruitment StatusNA
Primary outcomeChange in developmental quotient (DQ) measured using the MSEL, scored at 24 months
Key secondary outcomesChild development, autism symptoms, quality of life of parents, healthcare resource use.